Can money buy happiness? 7-year study answers famous question – Yahoo Finance Australia

Saint-Herblain (France), Sao Paulo, (Brazil), January 25, 2021 Valneva SE (Valneva or the Company), a specialty vaccine company focused on prevention of infectious diseases with significant unmet medical need, and Instituto Butantan, producer of immunobiologic products, today announced the signing of definitive agreements for the development, manufacturing and marketing of Valnevas single-shot chikungunya vaccine, VLA1553, in Low and Middle Income Countries (LMICs). This finalization follows the…

Click here to view the original article.